It turned out that there was no statistically significant relationship between the serum LECT2 content and diseases and conditions such as heart attack or stroke, hyperlipidemia, hypertension, diabetes, fatty liver, polyneuropathy, atherosclerosis of the limbs, chronic heart failure, insulin treatment, and metformin treatment. Here, LECT2 is linked to congestive heart failure.